α-galactosylceramide-induced airway eosinophilia is mediated through the activation of NKT cells

Journal of Immunology

Volumn 186, Issue 8, 2011, Pages 4687-4692

  Chuang, Ya Hui ^a   Wang, Tzu Chun ^a   Jen, Hsiao Yu ^a   Yu, Alice L ^b   Chiang, Bor Luen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; EOTAXIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5;

AIRWAY EOSINOPHILIA; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL INFILTRATION; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; EOSINOPHIL COUNT; FEMALE; FIBROBLAST; INFLAMMATION; INFLAMMATORY INFILTRATE; LOEFFLER PNEUMONIA; LUNG ALVEOLUS CELL; LUNG INFILTRATE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADMINISTRATION, INTRANASAL; ALUM COMPOUNDS; ANIMALS; ANTIGENS, CD1D; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; CHEMOKINES, CC; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; EOSINOPHILS; FEMALE; GALACTOSYLCERAMIDES; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; OVALBUMIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79955002652     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003659     Document Type: Article

References (51)

1. Cerundolo, V., J. D. Silk, S. H. Masri, and M. Salio. 2009. Harnessing invariant NKT cells in vaccination strategies. Nat. Rev. Immunol. 9:28-38.
2. Morita, M., K. Motoki, K. Akimoto, T. Natori, T. Sakai, E. Sawa, K. Yamaji, Y. Koezuka, E. Kobayashi, and H. Fukushima. 1995. Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice. J. Med. Chem. 38:2176-2187.
3. Courtney, A. N., P. N. Nehete, B. P. Nehete, P. Thapa, D. Zhou, and K. J. Sastry. 2009. α-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens. Vaccine 27:3335-3341.
4. Huang, Y., A. Chen, X. Li, Z. Chen, W. Zhang, Y. Song, D. Gurner, D. Gardiner, S. Basu, D. D. Ho, and M. Tsuji. 2008. Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide. Vaccine 26:1807-1816.
5. Youn, H.-J., S.-Y. Ko, K.-A. Lee, H.-J. Ko, Y.-S. Lee, K. Fujihashi, P. N. Boyaka, S.-H. Kim, T. Horimoto, M.-N. Kweon, and C.-Y. Kang. 2007. A single intranasal immunization with inactivated influenza virus and alphagalactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system. Vaccine 25:5189-5198. (Pubitemid 46907378)
6. Ko, S.-Y., H.-J. Ko, W.-S. Chang, S.-H. Park, M.-N. Kweon, and C.-Y. Kang. 2005. alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor. J. Immunol. 175:3309-3317. (Pubitemid 41170552)
7. Taniguchi, M., K.-i. Seino, and T. Nakayama. 2003. The NKT cell system: bridging innate and acquired immunity. Nat. Immunol. 4:1164-1165. (Pubitemid 37540684)
8. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25:297-336. (Pubitemid 46697911)
9. Yoshimoto, T., and W. E. Paul. 1994. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285-1295.
10. Stetson, D. B., M. Mohrs, R. L. Reinhardt, J. L. Baron, Z.-E. Wang, L. Gapin, M. Kronenberg, and R. M. Locksley. 2003. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198:1069-1076. (Pubitemid 37248622)
11. Godfrey, D. I., and M. Kronenberg. 2004. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114:1379-1388. (Pubitemid 40385565)
12. Van Kaer, L. 2007. NKT cells: T lymphocytes with innate effector functions. Curr. Opin. Immunol. 19:354-364. (Pubitemid 46687006)
13. Rothenberg, M. E., and S. P. Hogan. 2006. The eosinophil. Annu. Rev. Immunol. 24:147-174.
14. Bousquet, J., P. Chanez, J. Y. Lacoste, G. Barnéon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, et al. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039. (Pubitemid 20336962)
15. Lee, J. J., D. Dimina, M. P. Macias, S. I. Ochkur, M. P. McGarry, K. R. O'Neill, C. Protheroe, R. Pero, T. Nguyen, S. A. Cormier, et al. 2004. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305:1773-1776. (Pubitemid 39249644)
16. Haldar, P., C. E. Brightling, B. Hargadon, S. Gupta, W. Monteiro, A. Sousa, R. P. Marshall, P. Bradding, R. H. Green, A. J. Wardlaw, and I. D. Pavord. 2009. Mepolizumab and exacerbations of refractory eosinophilic asthma. N. Engl. J. Med. 360:973-984.
17. Walsh, E. R., N. Sahu, J. Kearley, E. Benjamin, B. H. Kang, A. Humbles, and A. August. 2008. Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma. J. Exp. Med. 205:1285-1292. (Pubitemid 351831486)
18. Jacobsen, E. A., S. I. Ochkur, R. S. Pero, A. G. Taranova, C. A. Protheroe, D. C. Colbert, N. A. Lee, and J. J. Lee. 2008. Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J. Exp. Med. 205:699-710. (Pubitemid 351439314)
19. Spencer, L. A., and P. F. Weller. 2010. Eosinophils and Th2 immunity: contemporary insights. Immunol. Cell Biol. 88:250-256.
20. Chuang, Y. H., C. L. Fu, Y. C. Lo, and B. L. Chiang. 2004. Adenovirus expressing Fas ligand gene decreases airway hyper-responsiveness and eosinophilia in a murine model of asthma. Gene Ther. 11:1497-1505.
21. Chang, M. C., R. D. Chen, and W. L. Ho. 1993. Intraoperative cytology: the use of Liu's stain for immediate diagnosis. Zhonghua Yi Xue Za Zhi (Taipei) 51:368-375.
22. Ye, Y. L., W. C. Huang, Y. L. Lee, and B. L. Chiang. 2002. Interleukin-12 inhibits eotaxin secretion of cultured primary lung cells and alleviates airway inflammation in vivo. Cytokine 19:76-84.
23. van Rijt, L. S., H. Kuipers, N. Vos, D. Hijdra, H. C. Hoogsteden, and B. N. Lambrecht. 2004. A rapid flow cytometric method for determining the cellular composition of bronchoalveolar lavage fluid cells in mouse models of asthma. J. Immunol. Methods 288:111-121. (Pubitemid 38739257)
24. Hausmann, O. V., T. Gentinetta, M. Fux, S. Ducrest, W. J. Pichler, and C. A. Dahinden. 2011. Robust expression of CCR3 as a single basophil selection marker in flow cytometry. Allergy 66:85-91.
25. Moore, M. L., D. C. Newcomb, V. V. Parekh, L. Van Kaer, R. D. Collins, W. Zhou, K. Goleniewska, M. H. Chi, D. Mitchell, J. A. Boyce, et al. 2009. STAT1 negatively regulates lung basophil IL-4 expression induced by respiratory syncytial virus infection. J. Immunol. 183:2016-2026.
26. Gessner, A., K. Mohrs, and M. Mohrs. 2005. Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J. Immunol. 174:1063-1072. (Pubitemid 40094303)
27. Sakuishi, K., S. Oki, M. Araki, S. A. Porcelli, S. Miyake, and T. Yamamura. 2007. Invariant NKT cells biased for IL-5 production act as crucial regulators of inflammation. J. Immunol. 179:3452-3462.
28. Li, L., Y. Xia, A. Nguyen, Y. H. Lai, L. Feng, T. R. Mosmann, and D. Lo. 1999. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J. Immunol. 162:2477-2487. (Pubitemid 29309264)
29. Matsukura, S., C. Stellato, S. N. Georas, V. Casolaro, J. R. Plitt, K. Miura, S. Kurosawa, U. Schindler, and R. P. Schleimer. 2001. Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. Am. J. Respir. Cell Mol. Biol. 24:755-761. (Pubitemid 32550599)
30. Meyer, E. H., S. Goya, O. Akbari, G. J. Berry, P. B. Savage, M. Kronenberg, T. Nakayama, R. H. DeKruyff, and D. T. Umetsu. 2006. Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc. Natl. Acad. Sci. USA 103:2782-2787.
31. Doucet, C., D. Brouty-Boyé, C. Pottin-Clémenceau, G. W. Canonica, C. Jasmin, and B. Azzarone. 1998. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J. Clin. Invest. 101:2129-2139. (Pubitemid 28244097)
32. Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103:779-788. (Pubitemid 29152623)
33. Akbari, O., J. L. Faul, E. G. Hoyte, G. J. Berry, J. Wahlström, M. Kronenberg, R. H. DeKruyff, and D. T. Umetsu. 2006. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med. 354:1117-1129.
34. Akbari, O., P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M. J. Grusby, R. H. DeKruyff, and D. T. Umetsu. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergeninduced airway hyperreactivity. Nat. Med. 9:582-588. (Pubitemid 36597105)
35. Lisbonne, M., S. Diem, A. de Castro Keller, J. Lefort, L. M. Araujo, P. Hachem, J. M. Fourneau, S. Sidobre, M. Kronenberg, M. Taniguchi, et al. 2003. Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 171:1637-1641. (Pubitemid 36966444)
36. Kinjo, Y., E. Tupin, D. Wu, M. Fujio, R. Garcia-Navarro, M. R.-E.-I. Benhnia, D. M. Zajonc, G. Ben-Menachem, G. D. Ainge, G. F. Painter, et al. 2006. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 7:978-986. (Pubitemid 44263912)
37. Kronenberg, M., and Y. Kinjo. 2009. Innate-like recognition of microbes by invariant natural killer T cells. Curr. Opin. Immunol. 21:391-396.
38. Kraft, M., G. H. Cassell, J. E. Henson, H. Watson, J. Williamson, B. P. Marmion, C. A. Gaydos, and R. J. Martin. 1998. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am. J. Respir. Crit. Care Med. 158:998-1001. (Pubitemid 28449473)
39. Pasternack, R., H. Huhtala, and J. Karjalainen. 2005. Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: a longitudinal analysis. J. Allergy Clin. Immunol. 116:1123-1128. (Pubitemid 41571798)
40. Kelly, J. T., and W. W. Busse. 2008. Host immune responses to rhinovirus: mechanisms in asthma. J. Allergy Clin. Immunol. 122:671-682; quiz 683-674.
41. Thomsen, S. F., S. van der Sluis, L. G. Stensballe, D. Posthuma, A. Skytthe, K. O. Kyvik, D. L. Duffy, V. Backer, and H. Bisgaard. 2009. Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. Am. J. Respir. Crit. Care Med. 179:1091-1097.
42. Kim, E. Y., J. T. Battaile, A. C. Patel, Y. You, E. Agapov, M. H. Grayson, L. A. Benoit, D. E. Byers, Y. Alevy, J. Tucker, et al. 2008. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med. 14:633-640. (Pubitemid 351809546)
43. Crowe, N. Y., M. J. Smyth, and D. I. Godfrey. 2002. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. J. Exp. Med. 196:119-127. (Pubitemid 34747317)
44. Choi, Y. S., T. Hoory, A. Monie, A. Wu, D. Connolly, and C. F. Hung. 2008. alpha-Galactosylceramide enhances the protective and therapeutic effects of tumor cell based vaccines for ovarian tumors. Vaccine 26:5855-5863.
45. Shimizu, K., Y. Kurosawa, M. Taniguchi, R. M. Steinman, and S. Fujii. 2007. Cross-presentation of glycolipid from tumor cells loaded with alphagalactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells. J. Exp. Med. 204:2641-2653. (Pubitemid 350063944)
46. Nieda, M., M. Okai, A. Tazbirkova, H. Lin, A. Yamaura, K. Ide, R. Abraham, T. Juji, D. J. Macfarlane, and A. J. Nicol. 2004. Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 103:383-389. (Pubitemid 38140063)
47. Ishikawa, A., S. Motohashi, E. Ishikawa, H. Fuchida, K. Higashino, M. Otsuji, T. Iizasa, T. Nakayama, M. Taniguchi, and T. Fujisawa. 2005. A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. Clin. Cancer Res. 11:1910-1917. (Pubitemid 40471857)
48. Uchida, T., S. Horiguchi, Y. Tanaka, H. Yamamoto, N. Kunii, S. Motohashi, M. Taniguchi, T. Nakayama, and Y. Okamoto. 2008. Phase I study of alphagalactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer. Cancer Immunol. Immunother. 57:337-345. (Pubitemid 350295376)
49. Kopecky-Bromberg, S. A., K. A. Fraser, N. Pica, E. Carnero, T. M. Moran, R. W. Franck, M. Tsuji, and P. Palese. 2009. Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine 27:3766-3774.
50. Kamijuku, H., Y. Nagata, X. Jiang, T. Ichinohe, T. Tashiro, K. Mori, M. Taniguchi, K. Hase, H. Ohno, T. Shimaoka, et al. 2008. Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses. Mucosal Immunol. 1:208-218. (Pubitemid 351541306)
51. Benoit, A. C., Y. Huang, S. Maneewatchararangsri, P. Tapchaisri, and R. Anderson. 2007. Regulation of airway eosinophil and neutrophil infiltration by alpha-galactosylceramide in a mouse model for respiratory syncytial virus (RSV) vaccine-augmented disease. Vaccine 25:7754-7762. (Pubitemid 47588530)